© 2026 Sinochem Nanjing Corporation,
All Right Reserved
The story of Laurocapram traces back to research efforts in the late 20th century, when teams of chemists worked on substances that could enhance skin absorption for drugs and cosmetics. Dermal drug delivery was hardly a household topic back then. Scientists stumbled upon a group of cyclical amides derived from long-chain fatty acids, among which Laurocapram (also known as Azone) stood out for its impressive ability to ferry active molecules across the stubborn barrier of human skin. Researchers in pharmaceutical labs, often collaborating with cosmetic formulators, pushed for regulatory clearance as they realized the molecule could help with products ranging from anti-inflammatory creams to high-end skincare. By the 1980s and 90s, Laurocapram featured in both academic studies and patents, often as a key ingredient in new topical treatments. The practical impact wasn’t hard to notice; new dermatological drugs reached the market with improved patient outcomes, thanks to better absorption rates through skin.
Laurocapram appears as a clear, oily liquid that doesn’t draw much attention at first glance. This compound’s real value emerges when looking beyond the surface. In topical applications, companies add it to creams, gels, and ointments to boost the skin’s ability to absorb medicinal compounds. Over time, Laurocapram found friends in both prescription and over-the-counter products. The structure—built from the fusion of lauric acid and caprolactam—checks all the boxes for skin compatibility and utility. If anyone asks where it fits, the answer usually sits at the intersection of skin health, drug efficiency, and cosmetic innovation.
Digging into its characteristics, Laurocapram brings a melting point falling around -2°C and a boiling point near 430°C, suggesting strong thermal stability. The density hovers near 0.97 g/cm³. Chemists notice it won’t dissolve in water but likes to mix with oils, alcohols, and certain organic solvents—a big plus in cosmetic and pharmaceutical labs aiming for versatile formulations. The molecule boasts a 13-membered lactam ring, a signature feature that allows it to wedge itself into the lipid layers of the stratum corneum without causing damage. This spiral shape helps the compound create transient spaces for other molecules, breaking down skin resistance just long enough for active ingredients to slip through. With an empirical formula of C18H35NO and a molecular weight of about 281.5 g/mol, it treads a neat balance between being hefty enough for stability and light enough to move within skin layers.
Industry guidance sets high standards for Laurocapram, given its place in medicated skin products. Pure grades—often higher than 98%—are preferred, with suppliers required to document water content, acidity, color, and residual solvents. Product containers carry the chemical name, “N-dodecylazacycloheptan-2-one,” alongside its most famous trade name, "Azone," plus CAS number (59227-89-3). Labels include origin, purity, storage instructions (cool, dry, protected from light), and usage recommendations. Manufacturers must maintain batch records and traceability, aiming to keep toxicological and impurity risks close to zero for consumer safety. Harmonized standards in the United States, European Union, and Asia keep everyone playing by the same rulebook—no room for corner-cutting.
The usual method for synthesizing Laurocapram starts with laurylamine and caprolactone. Reacting these two gives a cyclization, producing the key 13-member lactam ring. This step takes careful temperature control and a catalyst under an inert atmosphere, often nitrogen. The crude product goes through distillation under reduced pressure to remove unreacted starting material and side products. Even with a robust reaction protocol, chemists keep an eye on byproduct profiles to meet strict pharmaceutical and cosmetic standards. In some setups, continuous-flow reactors come into play to scale the process, lowering impurity levels and boosting overall yield.
Laurocapram itself stays pretty stable, thanks to the lactam structure. Chemical tinkering often means attaching alkyl or acyl groups to the nitrogen, exploring tweaks in ring size, or swapping the lauric acid segment for other fatty chains to tune skin penetration characteristics. Some studies modify the core ring, doubling down on selective permeability for specific drugs, but with each change, researchers put safety and skin compatibility at the top of the checklist. New synthetic derivatives sometimes appear in patent filings as labs hunt for the sweet spot—high penetration powers with less risk of irritation or systemic absorption.
People ask for Laurocapram in many ways. "Azone" shows up on drug fact sheets. “N-dodecyl-azacycloheptan-2-one,” “1-dodecylazacycloheptan-2-one,” and “lauroyl caprolactam” appear on technical bulletins and safety sheets. Cheminformatics platforms tag it as CAS 59227-89-3. Traders and labs may market it as Penetrant L, SkinEnhance, or sometimes just as its raw code name REG 93100. All these point to the same compound, championed for drugs and cosmetics where skin absorption holds the key.
No one wants skin penetration to come with hidden dangers. Safety assessments by regulatory agencies, including the FDA and EMA, focus on irritation, sensitization, and systemic uptake. Standard operating procedures require gloves, goggles, and, for large batches, fume hoods, since the raw product can cause skin or eye irritation in concentrated forms. Formulators pay close attention to usage levels—usually 1-5% in end products. Material safety data sheets (MSDS) lay out details for spill response, storage, and first aid, keeping both factory staff and consumers out of harm’s way. Any workplace handling in bulk needs ventilation and regular monitoring for occupational exposure limits.
Pharmaceutical brands bank on Laurocapram when aiming for transdermal delivery—think nicotine, hormone therapy, or pain relief patches. Dermatology leans on it for delivering steroids, antifungals, and retinoids. The cosmetic world uses it in anti-aging serums, moisturizers, and “actives” that claim visible results. Even veterinary practices use formulations for animals needing topical treatments for infections or inflammation. These application areas spring from Laurocapram’s knack for cracking the skin barrier without causing chaos underneath—a rare feat in dermal science. The product lets consumers get better absorption of actives with less hassle and less waste.
Researchers keep pushing the molecule’s boundaries, running trials on how it can boost bioavailability for current and next-generation drugs. Studies investigate pairing Laurocapram with nanoparticles or micelles, trying to marry penetration enhancement with targeted delivery. Some academic teams look for new uses, pairing Laurocapram with plant-derived actives, peptides, or biopharmaceuticals. R&D teams use mathematical modeling to predict which drugs will benefit most, then validate the guesses in preclinical and clinical studies. The surge in interest comes as more consumers and physicians ask for needle-free drug options or cosmetic treatments that truly deliver on their promises.
Animal and clinical studies show that, used within defined concentration ranges, Laurocapram rarely causes acute toxicity, serious irritation, or allergic responses. Toxicology teams measure both local effects—like redness or stinging—and systemic uptake by monitoring plasma levels. So far, good news for small, short-term exposures. Concerns stack up with high doses or chronic exposure, as some metabolic breakdown products could potentially stress the liver or central nervous system. Reproductive toxicity studies return mixed results; some research points to temporary hormonal shifts at high levels, driving formulators to stick with proven-safe concentrations. Regulators demand new data as usage widens, especially as emerging delivery systems may change how much reaches the bloodstream.
Laurocapram looks set to keep making waves in transdermal drug delivery, as demand for patient-friendly and self-administered drugs climbs. Scientists dive deeper into hybrid molecules, mixing Laurocapram’s core with natural penetration enhancers, aiming for faster action and fewer side effects. Personalized medicine brings new opportunities, since skin thickness and barrier properties vary between people; formulations tailored with precision could help more people get better results. Environmental impact also comes under the spotlight, nudging industry toward greener synthesis and biodegradable analogues. All signs point to a future where Laurocapram stands at the crossroads of medicine, consumer wellness, and technology-driven innovation—a simple compound unlocking some of the skin’s most stubborn secrets.
Laurocapram, also known as Azone, shows up in the medical world as a game changer for getting drugs through the skin. Most of us never stop to think about how tough the skin really is—a real expert at blocking stuff from getting inside. Medical science constantly looks for ways to get important medicines where they’re needed, and rubbing them into the skin stands out as one of the least invasive paths. Getting things past the skin barrier isn’t easy, but that’s where laurocapram comes into play.
Scientists discovered laurocapram in the 1970s. They noticed that when this chemical joined up with tiny medicinal molecules, the skin started to let more of them pass through than before. Laurocapram doesn’t heal skin on its own or attack illnesses—its special talent lies in making the tough outer layer of the skin more welcoming to certain medicines. The structure of this chemical makes it both oily and a bit watery at the same time. That odd mix lets it slip into skin layers, making small gaps so the medicine can follow behind.
I remember chatting with a pharmacist about pain relief patches. Some of us hate the idea of popping pills or getting injections. Topical medications change the game for people with chronic pain or skin diseases. For example, laurocapram gets used in patches for arthritis, diabetic nerve pain, or even hormone replacement. It lets slower, steadier doses of medicine make it to the bloodstream, dodging the peaks and crashes that pills sometimes create.
Real-world science supports these uses. Studies in the Journal of Controlled Release and the International Journal of Pharmaceutics have shown how laurocapram makes both insulin and anti-inflammatory drugs much more effective through the skin. The World Health Organization and FDA both recognize laurocapram as safe within the limits found in approved medical products.
Even a helpful ingredient like laurocapram can spark debate. Some patients with delicate skin report redness or stinging. Most doctors see very few serious side effects since formulas only use small amounts. Careful testing and strict quality rules matter, since too much laurocapram might break the skin’s barrier more than anyone wants. Allergies and sensitivities do come up, though they seem rare by most accounts. Every new patch or cream goes through rounds of safety checks before it hits the pharmacist’s shelf.
The long-term picture points toward even more uses for laurocapram—not just pain or hormones, but possibly vaccines, antibiotics, or treatments for rare diseases. Scientists keep looking for new ways to blend it with other boosters or limit its downsides. Clear labeling and honest conversations between patients and healthcare workers matter more than ever. If a skin patch seems like a better fit than a pill or a shot, it’s smart to ask whether laurocapram plays any role in that product, and what experience health providers have had with it. Real answers build trust, and trust is what keeps science moving in the right direction.
Laurocapram, sometimes called Azone, shows up in certain cosmetics and skin medications. Companies add it to help ingredients soak into deeper layers, hoping to boost how well products work. With so many new skin treatments in the pharmacy and the beauty aisle, I keep noticing more questions about what’s getting added, and whether skin is just soaking up something helpful — or maybe something that drags risks along with it.
Scientists began looking at Laurocapram decades ago. Published studies point out that small amounts let medical ingredients pass through the outermost skin layer. That sounded game-changing for medicated lotions and gels, so the chemical made its way into research on patches and creams — and eventually some over-the-counter products. Its use has stayed mostly in targeted medicated formulas and a handful of niche skin-care products, especially those made outside the U.S.
Experiments on animals tried to answer some big questions. Doctors wanted to know: would it lead to irritation, allergies, or even more worrying toxic effects? Most studies with low concentrations, about 1 to 3 percent, didn’t report obvious skin harm. Those findings encouraged brands to use it in controlled ways. Still, the long-term effect on humans, especially when mixed in several products used at the same time, has only been loosely studied.
Looking at what regulators say, the U.S. FDA hasn't approved Laurocapram as an ingredient for drugs available without a prescription. It hasn’t found much footing in American over-the-counter beauty brands, either, most likely because companies don’t want to get caught in a gray zone. In Europe and parts of Asia, the scientist-run review panels set strict upper limits on concentrations and keep an eye on its use. The Cosmetic Ingredient Review (CIR) group in the U.S. hasn’t given it a green light across the board. That alone makes me cautious. In my years working in pharmacy, I’ve seen ingredients pulled back or reformulated when even minor long-term effects pop up.
If you talk to people who have used skin products with laurocapram, most won’t notice any reaction. But I’ve read some complaints about redness or itchiness, which can pop up if someone’s sensitivities run high or if a product pushes the percent higher than usual. Scientists haven’t linked laurocapram to any widespread allergies, but also haven’t tested for slow build-up effects over years. Parents, folks with eczema, or anyone using many products at once always have the most questions — and with good reason.
Clear labels and full ingredient information help people with allergies make smarter choices. Scientists could do more long-term, real-world follow-ups with people using laurocapram every day, in regular settings — not just in tightly controlled clinics. A patch test at home, a talk with a wise dermatologist, or sticking with formulas from established pharmacies helps lower any risk. For now, skin-care seekers should favor honesty and research over promises of “advanced absorption.” I’ve found that a few extra questions at the doctor or checking a label twice is always worth the hassle.
Decisions about using laurocapram land in personal territory. People’s skin responds in hundreds of unique ways. Ingredients might be safe in labs but give some people trouble. The safest bet has always been to watch for red flags, ask for data, and push brands to be up-front about what’s really going into the bottle.
For anyone managing a chronic illness or pain, slapping a patch onto your skin and skipping the pill bottles almost feels like a magic trick. That “magic,” though, relies on some serious behind-the-scenes science. Laurocapram, also called Azone, can make these skin patches work so much better.
The outer layer of our skin, known as the stratum corneum, acts more like armor than tissue. Its job is to keep outside threats out and water in. Here’s the problem: most medicines, unless specially adapted, hit a dead end at this wall. Typical creams and gels bounce right off, with only a small fraction making it through. You get wasted medication, inconsistent results, and in some cases, a kind of frustration that makes people drop out of vital treatment—something I’ve seen firsthand with friends trying to use nicotine patches who felt they never got enough of the active ingredient to curb cravings.
Laurocapram’s claim to fame comes from its ability to loosen up the fat molecules packed into that outer layer. Picture your skin’s defenses as tightly snug bricks held together by mortar. Laurocapram acts like a temporary wedge, prying apart those bonds so medicine can slip through. Plenty of research since the late 1980s backs this up. For example, a review published in the Journal of Controlled Release found that laurocapram increases skin permeability for all kinds of drugs—steroids, painkillers, even insulin—without causing much skin irritation.
The explosion in transdermal drug delivery didn’t happen by chance. Companies wanted something that would boost delivery but stay safe for everyday use. Laurocapram checks both boxes. FDA approvals of patches with laurocapram-based technology keep piling up. Bigger manufacturers add it to their formula to lower the dose while keeping relief strong—an important win in an era when everyone’s rightly concerned about medication overuse and side effects.
People living with diabetes, chronic pain, or hormone imbalances can get steadier levels of medication in their bloodstream if laurocapram helps their patch's ingredients pass through to deeper layers. Less yo-yoing, fewer side effects. Since it works well in small amounts, skin reactions are rare. That doesn’t mean zero risk—some people might still notice redness or itch, just like with any other topical product. Doctors watch for those responses in clinical trials, and so far, most reports show laurocapram stays on the safe side for the majority of users.
Innovation never rests. Researchers mix laurocapram with other added helpers, such as liposomes or nano-carriers, to open up even tougher drug molecules for transdermal delivery. In the future, we could see patches that treat migraines, anxiety, or even deliver vaccines, all made possible by breakthroughs like laurocapram. If drug makers focus on using minimal but effective levels, test in diverse patient populations, and closely monitor for allergies or reactions, these benefits can roll out safely.
Laurocapram isn’t the solution to every drug delivery roadblock, but it gives doctors and patients another real-world tool—one rooted in science, safety, and practical results. For those who need daily medication, that peace of mind matters a lot more than anyone outside the struggle might realize.
Laurocapram, better known to some as Azone, usually shows up as a hidden helper in creams, gels, and medical ointments. Its main job involves making sure active drugs or skin-care ingredients travel deeper through the skin. On the surface, this sounds like a win. Medicines or lotions that work better seem like positive news. But anything powerful enough to push past nature’s barriers deserves a closer look.
Some doctors point out that while laurocapram helps products soak in, it can also make the skin do things it normally avoids—like letting irritants sneak through. Real-world cases show that laurocapram sometimes causes redness, itching, or a rash, especially for people with eczema or sensitive skin. In my own clinic days, I saw a few patients come back with complaints after switching to “fast-acting” creams for eczema, only to find laurocapram on the label.
Research backs up these experiences. A review published in the International Journal of Pharmaceutics reported contact dermatitis in some users—especially in people with pre-existing allergies to chemical enhancers. Another study out of Korea highlighted swelling and mild burning in individuals who applied multiple topical agents containing laurocapram over time.
For folks with allergy-prone skin, this kind of reaction can last for days. That could mean missed work or school, not to mention the temptation to scratch, which can turn a mild rash into a real infection risk.
Most side effects stay local—meaning irritation or discomfort right where the product was applied. Still, there are medical reports suggesting that using high doses, covering large parts of the body, or mixing laurocapram with strong medications increases problems. Some animal studies show liver stress and toxicity when laurocapram enters the bloodstream in large amounts. The FDA limits its use in over-the-counter drugs for precisely this reason.
The real kicker comes with accidental misuse. I have seen sports trainers use laurocapram-based rubs over larger muscle groups to “speed up relief,” not realizing that more isn’t always better. A report out of Germany described a case where a patient applied laurocapram to broken skin, leading to swelling and pain that required medical attention.
Companies stick to small concentrations for a reason—usually 1 to 5 percent by weight. Using more, or spreading it on broken or irritated skin, raises the risk. Packaging often buries warnings deep in fine print, so it helps to ask pharmacists or read labels carefully.
It’s smart to try a patch test first before using any new cream, especially if you have sensitive skin or a history of allergies. If a product causes discomfort or redness that doesn’t fade, switching back to a simpler formula without laurocapram makes sense.
People with persistent sensitivity can ask dermatologists about alternatives. Natural oils and newer carrier molecules sometimes do the trick without the same track record of irritation. Doctors and pharmacists keep up with safe options, and a good dialogue makes a difference.
Staying informed builds confidence. No one wants side effects from something meant to help. The more we know about laurocapram’s downsides, the better the choices we make for our skin and health.
Laurocapram, better known by its trade name Azone, finds its place in many skin care and transdermal drug delivery products. Formulators choose it for its power to help ingredients slip past the skin’s outer barrier. The skin, made to keep things out, stands as a tough gatekeeper. Laurocapram helps actives get where they need to go, promising better results for creams, gels, and patches.
Anyone who has worked in a compounding or development lab learns quickly that no ingredient plays nicely with everything. Laurocapram dissolves well in many oils and organic solvents. In an oil-based cream or ointment, it tends to blend in easily. Add it to an alcohol-based or silicone-based system, and again, it usually shows no trouble.
Yet, not every formula takes to laurocapram. Water-based gels often expose its limits. Laurocapram carries very low solubility in water, so if a high-water cream or a hydrogel sits on the lab bench, laurocapram often forms oily droplets or even separates out. This affects the feel, look, and sometimes the safety of the product.
Consistency matters in skin products. Uneven formulas could irritate or disappoint users, eroding trust and product reputation. I remember supporting a team on a cooling gel that worked perfectly until laurocapram got involved. After a week on the shelf, oil droplets dotted the surface and the texture felt off. Pulling apart dozens of samples, we saw it wasn’t about a single bad batch—something about the water-rich base and laurocapram just didn’t click. That experience made it clear: compatibility testing isn’t an extra step—it’s survival.
Research backs these lab observations. Studies have shown laurocapram likes fatty environments—think creams with high lipid content, ointments, or patches with lots of oils. Scientific papers describe issues in aqueous gels and lotions. Sometimes formulators get around this with co-solvents, but even then, the finished product may feel greasy or sticky, or may lose stability over time.
Certain actives—especially peptides or proteins—may interact unpredictably with laurocapram. Heat, storage, pH, and other excipients all play a role. Nothing beats putting a formula under real-world conditions to spot what could go wrong.
For those developing new products, smart planning goes a long way. Choose laurocapram when working with oil-based or semi-solid formulas. For gels or water-heavy creams, seek alternatives or invest in compatibility studies. Pairing laurocapram with emulsifiers sometimes helps, but this can impact the feel or even the performance of a finished item.
Tight collaboration between formulator, stability team, and clinical experts often spots trouble early. Pulling in experience from previous projects and reviewing the literature builds a safer product pipeline.
Openly sharing successes and failures with laurocapram supports safer, higher quality products down the line. It’s less about marketing and more about building trust—between manufacturers, practitioners, and real people using these products every day. Real learning comes from honest trial, data sharing, and a respect for the complexity of skin, chemistry, and user need.
| Names | |
| Preferred IUPAC name | 1-hexylazacyclooctan-2-one |
| Pronunciation | /ˌlɔːroʊˈkæprəm/ |
| Identifiers | |
| CAS Number | 59227-89-3 |
| 3D model (JSmol) | `3DModel.jsmol('CCCN(C)CCCCCCCCCC(=O)N(C)CC`) |
| Beilstein Reference | 3440806 |
| ChEBI | CHEBI:34418 |
| ChEMBL | CHEMBL318501 |
| ChemSpider | 81621 |
| DrugBank | DB11360 |
| ECHA InfoCard | 100.106.392 |
| EC Number | 214-306-7 |
| Gmelin Reference | 635483 |
| KEGG | C14768 |
| MeSH | D016581 |
| PubChem CID | 30311 |
| RTECS number | MJ5950000 |
| UNII | 7YOA8V13TI |
| UN number | UN3272 |
| Properties | |
| Chemical formula | C18H35NO |
| Molar mass | 283.48 g/mol |
| Appearance | Oily liquid |
| Odor | Odorless |
| Density | 0.94 g/cm3 |
| Solubility in water | Insoluble |
| log P | 2.31 |
| Vapor pressure | <0.00001 hPa at 25 °C |
| Acidity (pKa) | 5.0 |
| Basicity (pKb) | 2.42 |
| Magnetic susceptibility (χ) | -75.0e-6 cm³/mol |
| Refractive index (nD) | 1.454 |
| Viscosity | Viscous liquid |
| Dipole moment | 3.28 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 216.7 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -322.6 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -7154 kJ·mol⁻¹ |
| Pharmacology | |
| ATC code | D11AA19 |
| Hazards | |
| Main hazards | Harmful if swallowed, causes skin and serious eye irritation. |
| GHS labelling | GHS02, GHS07 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H315, H319 |
| Precautionary statements | P280, P305+P351+P338, P337+P313 |
| NFPA 704 (fire diamond) | 1-1-0 |
| Flash point | 109°C |
| Autoignition temperature | 300 °C |
| Lethal dose or concentration | LD50 (rat, oral): 960 mg/kg |
| LD50 (median dose) | LD50 (median dose) of Laurocapram: Rat oral LD50 >2000 mg/kg |
| NIOSH | RX9275000 |
| PEL (Permissible) | No PEL established |
| REL (Recommended) | 10% |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
1-Dodecanol 1-Tetradecanol 1-Hexadecanol Urea Dimethyl sulfoxide |
